Sign in

CIK 0001583648

  • Non-accelerated filer
  • Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
300784346
Phone
+1 484-253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,071,070
in 6 filings, $11.0M under 10b5-1 plans

Net −$11,071,070. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-02-26 Reine Allan Chief Financial Officer Grant or award · Stock Options (Right to Buy) +162,500 162,500
2018-02-20 Reine Allan Chief Financial Officer Grant or award · Stock Options (Right to buy) +53,833 53,833
2018-02-20 Reine Allan Chief Financial Officer Grant or award · Stock Options (Right to buy) +50,000 50,000
2017-08-17 Reine Allan Purchase +20,000 $4.89 $98K 65,000
2017-08-16 Reine Allan Purchase +45,000 $4.79 $216K 45,000
2017-08-09 Reine Allan Grant or award · Common Stock +450,000 450,000

Page 1 of 1 · 6 trades